Cough Syrup Ban (Cough Syrup Ban)
The central government has taken a major decision to prohibit cough syrup sales without an authorised doctor’s prescription. Until now most syrups were sold over the counter, but after recent child death cases the government has acted urgently. The country's top regulatory drug advisory committee approved the decision during its 67th meeting.
Officials observed that unrestricted access to such syrups has led to unsafe self-medication. Authorities believe controlled sale will prevent misuse and ensure expert supervision. The move is being viewed as a strong measure to protect public health.
Recently in Madhya Pradesh at least several children reportedly died after consuming cough syrup without proper medical guidance. These tragic incidents created panic across the state and later nationwide. Following this, the government decided to treat the matter with high seriousness. Under the new regulation, pharmacists will not be permitted to hand over cough syrups unless a valid medical prescription is presented. The aim is to stop unrestricted medication use and ensure treatment only under doctor supervision. This decision has been welcomed by health experts.
Cough syrups have been removed from the category of medicines that can be sold over the counter. Pharmacies across the country must now strictly follow prescription-based sale. According to the government, caution is necessary because many people were using these drugs without medical requirement and even for addiction. There were concerns that such misuse weakens antibiotic effects and contributes to resistance. Officials say that with medical guidance unnecessary consumption will reduce. This move aims to cut down irresponsible drug use significantly.
Reports suggest that not only India but other countries also faced similar tragedies linked to contaminated cough syrups. In Uzbekistan, 68 children died after allegedly consuming Indian-made syrup, resulting in legal action against 21 individuals. In Indonesia, more than 200 children lost lives between 2022 and 2023 due to similar incidents. Comparable cases were also reported in Gambia. These international events damaged India’s global image. Hence the government decided to regulate cough syrups more strictly to restore trust and ensure safety.
After these incidents, the World Health Organisation investigated and identified three contaminated medicines produced in India. These included Coldrif by Srisan Pharmaceuticals, Respifresh TR by Rednex Pharmaceuticals and Relife by Shep Pharma. WHO warned global authorities to avoid their use. According to health experts, improper ingredients and poor manufacturing standards caused toxic effects on children's organs. The Indian government has since strengthened drug monitoring systems and increased scrutiny of pharmaceutical companies involved in syrup production.
Government officials believe that restricting direct sale will reduce chances of self-medication and overdose. Moving forward, people will be required to consult doctors for cough treatment which ensures proper diagnosis. The decision also helps prevent drug abuse as some syrups were allegedly being used for intoxication. Authorities also highlight that antibiotic misuse leads to reduced effectiveness when genuinely needed. By involving medical professionals more, future risks can be minimised effectively and patient safety improved.
Patients experiencing cough or cold symptoms must now visit a qualified doctor before buying any syrup. They should carry the prescription to the pharmacy to receive the medication. Experts advise against consuming leftover or previously stored syrups without medical consultation. Parents are requested to be extra careful while giving medicine to children. The regulation is expected to promote safer treatment practices. Health ministry recommends that public follow rules strictly to avoid further incidents and support preventive healthcare.
Copyright © 2025 Top Indian News
